Abstract:Key PointsCRISPR–Cas (clustered regularly interspaced short palindromic repeats–CRISPR-associated proteins) is an adaptive immune system in bacteria and archaea, which is categorized into three distinct types (known as type I, type II and type III) that differ in their compositions and mechanisms of action. Adaptive immunity occurs in three distinct stages: acquisition, expression and interference.In all three types of CRISPR–Cas system, spacer acquisition relies on a pair of conserved Cas proteins (Cas1 and Cas2), which are probably assisted by a variable set of additional (potentially both Cas and non-Cas) enzymes.Primary processing of CRISPR RNAs (crRNAs) is catalysed either by Cas6-like ribonucleases (in the type I and type III systems) or by RNase III (which targets the crRNA and transactivating crRNA (tracrRNA) duplex in type II systems).Mature crRNAs form CRISPR ribonucleoprotein (crRNP) complexes by associating with either Cascade-like multiprotein complexes (in type I and type III systems) or the multidomain Cas9 protein (in type II systems).Discrimination of 'self' nucleic acid from 'non-self' nucleic acid enables crRNP complexes to specifically target invading nucleic acid (usually DNA). Some complexes recruit additional nucleases (for example, Cas3 in type I systems), whereas other crRNPs have intrinsic nuclease domains (for example, Cas9 in type II systems).Fundamental studies have elucidated many mechanistic features of CRISPR–Cas functionality by integrating genetics, biochemistry and structural biology. This has provided an excellent basis for developing a wide range of applications, from the manipulation of gene expression in bacteria to genome editing in eukaryotes.

Degenerated CRISPRs widely regulate Cas expression to balance immunity and cost

Widespread RNA-based cas regulation monitors crRNA abundance and anti-CRISPR proteins

Cas9 interaction with the tracrRNA nexus modulates the repression of type II-A CRISPR-cas genes

CdpR Inhibits CRISPR-Cas Adaptive Immunity to Lower Anti-viral Defense While Avoiding Self-Reactivity.

crRNA complementarity shifts endogenous CRISPR-Cas systems between transcriptional repression and DNA defense

CRISPR-Cas supervises diverse anti-phage defense systems

CRISPR-repressed toxin-antitoxin provides population-level immunity against diverse anti-CRISPR elements

Unravelling the structural and mechanistic basis of CRISPR–Cas systems

Unmodificated stepless regulation of CRISPR/Cas12a multi-performance

Phage CRISPR-like regulatory RNAs silence bacterial adaptive and innate immunity

High-throughput screen reveals sRNAs regulating crRNA biogenesis by targeting CRISPR leader to repress Rho termination

Multiplex gene regulation by CRISPR-ddCpf1

Structural and functional insights into the type III-E CRISPR-Cas immunity

Pro-CRISPR PcrIIC1-associated Cas9 system for enhanced bacterial immunity

LrhA promotes CRISPR-Cas immunity by enhancing primed adaptation in

CRISPR-repressed toxin-antitoxin provides herd immunity against anti-CRISPR elements

Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression

Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering

Diverse viral cas genes antagonize CRISPR immunity

Multifactorial control of the expression of a CRISPR-Cas system by an extracytoplasmic function σ/anti-σ pair and a global regulatory complex

Mechanisms regulating the CRISPR-Cas systems